Can Crocs Continue Its Quest for New Highs?


On Thursday, the shares of Crocs, Inc. (CROX) shuffled to a new 52-week high for the second time in as many sessions. The equity topped out at $8.47 on an intraday basis, marking its best price since July 2008. But with the stock hovering near a 20-month peak, can the shares continue to climb -- or are they due for a pullback?

If today's drop of more than 2% is any indication, it seems that CROX's positive momentum is cooling. The stock's Relative Strength Index (RSI) stands at 63, not far from overbought territory, so this modest retreat isn't terribly surprising.


The stock's fans will note that CROX's slip today has so far been contained by tentative support at its 10-day moving average. From a longer-term perspective, the shares have enjoyed the unflagging support of their 10-week trendline since late December 2009; in the intervening months, CROX hasn't endured a single weekly close below this moving average.

However, it would also be fair to observe that the stock hasn't finished a single week above $8 per share since July 2008. This region has capped CROX's rally attempts consistently, despite multiple challenges during the previous six months.

Plus, beyond the troublesome $8 level is the psychologically critical $10 neighborhood. Since the stock has been languishing in single-digit territory for nearly two years, this round-number level could prove a troublesome hurdle to overcome.

While there are certainly some serious obstacles looming overhead, CROX doesn't quite seem poised to plunge. In addition to the aforementioned layers of technical support, there's also a healthy amount of pessimism priced into the stock. When expectations are already running low, there's a relatively lower chance for staggering sell-offs.

As evidence of this skepticism, short interest accounts for a robust 10.5% of the security's float. Option traders are also leaning bearish, with CROX's 10-day International Securities Exchange (ISE) put/call volume ratio of 0.39 ranking higher than 81.4% of other such readings taken during the past year. This elevated percentile rank reveals that speculators have rarely bought to open puts over calls at a faster pace.

This healthy amount of pessimism suggests that additional downside could be relatively limited, but that's hardly a ringing bullish endorsement. With CROX pinned between support and resistance on the charts, the stock needs to find a way to impress the skeptics before it can find the momentum to move higher. For a company that's struggling to return to profitability, that could be a pretty tall order.

Elizabeth Harrow is a senior equities analyst and financial writer in the research department at Schaeffer's Investment Research. She is featured in the video series Schaeffer's Daily Q&A on SchaeffersResearch.com.

Symbol Lookup
IndexesChangePrice
DJIA-89.2312,801.23
NASDAQ-23.352,903.88
S&P 500-9.311,342.64

Last updated: February 10, 2012: 05:25 PM

Hot Stocks

General Electric

18.875-0.255(-1.33)

Alcoa

10.29-0.35(-3.29)

Apple Inc

493.42+0.25(+0.05)

Google Inc 'A'

605.91-5.55(-0.91)

Bank of America

8.07-0.11(-1.34)

Wal-Mart Stores

61.90-0.06(-0.10)

Exxon Mobil Corp

83.80-1.08(-1.27)

Ford

12.44-0.25(-1.97)

Citigroup

32.925-0.735(-2.18)

IBM

192.42-0.71(-0.37)

Yahoo

16.14+0.14(+0.88)

Starbucks

48.82-0.38(-0.77)

Microsoft

30.495-0.275(-0.89)

Home Depot

45.33+0.06(+0.13)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

BioHealth Investor Headlines

WalletPop Headlines

DailyFinance BlackBerry App

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance

BioHealth Investor Headlines

Page Loaded in 1328912736268 ms.